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This study aims to evaluate the in vitro cytotoxic and anti-migratory effects of Ficus
deltoidea L. on prostate cancer cells, identify the active compound/s and characterize
their mechanism of actions. Two farmed varieties were studied, var. angustifolia
(FD1) and var. deltoidea (FD2). Their crude methanolic extracts were partitioned into
n-hexane (FD1h, FD2h) chloroform (FD1c, FD2c) and aqueous extracts (FD1a, FD2a).
Antiproliferative fractions (IC50 < 30 µg/mL, SRB staining of PC3 cells) were further
fractionated. Active compound/s were dereplicated using spectroscopic methods.
In vitro mechanistic studies on PC3 and/or LNCaP cells included: annexin V-FITC
staining, MMP depolarization measurements, activity of caspases 3 and 7, nuclear
DNA fragmentation and cell cycle analysis, modulation of Bax, Bcl-2, Smac/Diablo,
and Alox-5 mRNA gene expression by RT-PCR. Effects of cytotoxic fractions on 2D
migration and 3D invasion were tested by exclusion assays and modified Boyden
chamber, respectively. Their mechanisms of action on these tests were further studied
by measuring the expression VEGF-A, CXCR4, and CXCL12 in PC3 cells by RT-PCR.
FD1c and FD2c extracts induced cell death (P < 0.05) via apoptosis as evidenced
by nuclear DNA fragmentation. This was accompanied by an increase in MMP
depolarization (P < 0.05), activation of caspases 3 and 7 (P < 0.05) in both PC3
and LNCaP cell lines. All active plant extracts up-regulated Bax and Smac/DIABLO,
down-regulated Bcl-2 (P < 0.05). Both FD1c and FD2c were not cytotoxic against
normal human fibroblast cells (HDFa) at the tested concentrations. Both plant extracts
inhibited both migration and invasion of PC3 cells (P < 0.05). These effects were
accompanied by down-regulation of both VEGF-A and CXCL-12 gene expressions
(P < 0.001). LC–MS dereplication using taxonomy filters and molecular networking
databases identified isovitexin in FD1c; and oleanolic acid, moretenol, betulin, lupenone,
and lupeol in FD2c. In conclusion, FD1c and FD2c were able to overcome three main
hallmarks of cancer in PC3 cells: (1) apoptosis by activating of the intrinsic pathway,
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(2) inhibition of both migration and invasion by modulating the CXCL12-CXCR4 axis,
and (3) inhibiting angiogenesis by modulating VEGF-A expression. Moreover, isovitexin
is here reported for the first time as an antiproliferative principle (IC50 = 43 µg/mL, SRB
staining of PC3 cells).
Keywords: apoptosis, migration, invasion, PC3, LNCaP, prostate cancer, Ficus deltoidea
INTRODUCTION
Prostate cancer is considered as one of the most common types of
cancer in the world, which affect mostly in the western societies.
It is estimated that, 1.1 million men worldwide were diagnosed
with prostate cancer in 2012, which account for almost 15% of the
cancers diagnosed in men. 70% of these cases occurred in more
developed nations and this could be due to the practice of prostate
specific antigen (PSA) testing and subsequent biopsy that has
become widespread in this part of the world. 307,000 estimated
deaths were reported in 2012 which make prostate cancer as the
fifth leading cause of death from cancer in men (6.6% of the
total men deaths) (Ferlay et al., 2013). In the United Kingdom,
prostate cancer contributed to the 46,690 (13%) new cases and
11,287 deaths annually. Almost half, 54%, of the prostate cancer
cases in the United Kingdom are diagnosed in males aged 70
and over every year (Cancer Research UK, 2016). According to
the statistics provided by the National Cancer Registry, Ministry
of Health Malaysia (2011) of Malaysia, prostate cancer ranked
ninth overall and is the fourth most frequent cancer (7.3% of all
cancers) diagnosed in men. Although the incidence of prostate
cancer is more prevalent in the western countries, the number of
prostate cancer cases has also grown rapidly in Asian countries
such as Japan, and Hong Kong (Wynder et al., 1991; Liu et al.,
1993). Initially, this phenomenon was linked to the influx of
Western food restaurants and franchises in most of the Asian
continent that have led to the change of the normal dietary
pattern of Asians. However, numerous studies made clear that
even though diet could be one of the risk factors for prostate
cancer, it only has a week association with the disease. Direct
risk factors such as age, ethnicity, family history, and genetic
conditions are reported to play major role in the onset of prostate
cancer.
Approximately 90% of androgen-dependent prostate cancer is
detected either locally or at regional stages, thus explaining the
high cure rate, as nearly 100% of men diagnosed and treated
at this stage will be disease free after 5 years. However, many
men die as therapy eventually fails when the disease progresses
to androgen-independent stage (Feldman and Feldman, 2001).
This stage of prostate cancer is lethal and has the ability to
progress and metastasize. At present, there is no effective therapy
that can be used for men diagnosed with androgen-independent
prostate cancer. There is a need for chemopreventive products
targeting middle-aged men. This is because treatment results
are not sustainable for the health system, which does not cover
all the population. Developing such a product from traditional
medicinal plants would facilitate better compliance among a lot
of patients as the use of traditional plants and herbs are culturally
embedded into the local lifestyle.
Traditional herbal medicines are still very important for
Malaysians both from a nutritional and a medicinal point of
view. One of the most common herbs used in Malaysia includes
Ficus deltoidea L. Ficus deltoidea is a native shrub, which belongs
to the family of Moracea. The plant is characterized by the
evergreen small tree or shrub and in the wild the plant can reach
around 5–7 m tall. This species of plant can normally be found
in southeast Asian countries including Malaysia, Indonesia, and
southern Philippines. It is commonly known as “Mas Cotek” in
the peninsular Malaysia and people in east Malaysia normally
refer to this plant as “sempit-sempit” and “agolaran” (Berg,
2003). This plant plays an important role in traditional medicine,
where different parts of the plant is used for the treatment of
several conditions such as the relief of headache (fruit part),
toothache (fruit part), and sores and wound (roots and leaves).
Women consume the decoction of boiled leaves of F. deltoidea as
postpartum treatment to induce the contraction of the uterus and
vaginal muscles besides treating the disorders of the menstrual
cycle and leucorrhoea (Burkill and Haniff, 1930).
Despite this plant species having many important applications
traditionally, only few studies have been conducted to explore
its potential pharmacological properties. Some reported that
flavonoids are one of the phytochemical compounds that can be
found in abundance in F. deltoidea which includes gallocatechin,
epigallocatechin, catechin, gallic acids, ellagic acids, luteolin-8-C-
glucoside, 4-p-coumaroylquinic acid, orientin, vitexin, isovitexin,
rutin, quercetin, and naringenin (Bunawan et al., 2014;
Ramamurthy et al., 2014). The presence of these phytochemicals
gives its yellow pigmentation, and many studies established that
any herbs containing flavonoids could have the ability to acts as
anti inflammatory, anti allergy, anti cancer and anti microbial
agents, thus explaining how the plant is able to protect itself
from the damaging acts of insects and microorganism (Abdullah
et al., 2009; Uyub et al., 2010; Akhir et al., 2011; Zakaria et al.,
2012).
Flavonoids such as epigallocatechin has been reported to have
the ability to inhibit the growth of prostate cancer cells, PC3
(Albrecht et al., 2008). Zhou et al. (2009) has reported that
vitexin showed cytotoxic effect on breast, ovarian and prostate
cancer cells by inducing apoptosis with the cleavage of PARP
protein, up-regulation of Bax and downregulation of Bcl-2.
Gallic acid is identified as the major anticancer compound in
T. sinensis leaf extract. Studies conducted using this extract have
shown that gallic acid is cytotoxic against DU145 prostate cancer
cells through generation of reactive oxygen species (ROS). It is
also capable of blocking the growth of DU145 cells at G2/M
phases by activating Chk1 and Chk2 and inhibiting Cdc25C
and Cdc2 (Chen et al., 2009). Natural antioxidant such as
ellagic acid has been reported to have anti-proliferative and
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pro-differentiation properties against prostate cancer cells by
decreasing eicosanoid synthesis and downregulating the heme
oxygenase system in prostate cancer cells (Vanella et al., 2013).
Rutin, quercetin, and orientin have been reported to have
anticancer properties by inducing apoptosis in murine leukemia
WEHI-3 cells (rutin) (Lin et al., 2012), human lung cancer
cell line A-549 (quercetin) (Zheng et al., 2012), and human
cervical carcinoma cells, HeLa (orientin) (Guo et al., 2014).
Ficus species that are reported to contain phenanthroindolizidine
alkaloids and a series of triterpenoids with C-28 carboxylic acid
functional groups demonstrate very strong cytotoxic compounds.
For example, triterpenoids which were isolated from the aerial
roots of Ficus microcarpa demonstrated cytotoxicity in three
human cancer cell lines including HONE-1 nasopharyngeal
carcinoma cells, KB oral epidermoid carcinoma cells, and HT29
colorectal carcinoma cells with IC50 values from 4.0 to 9.4 µM
(Chiang and Kuo, 2002; Chiang et al., 2005). Since all these
active phytochemicals were reported to be available in F. deltoidea
L. (Bunawan et al., 2014), the plant could play a vital role in
the inhibition of prostate cancer cells. With this in mind, the
main aim of this research is to investigate both the cytotoxic
effect and pro-apoptotic activities of F. deltoidea L., identify the
bioactive compounds, and characterize the main mechanisms of
the cytotoxic activity.
MATERIALS AND METHODS
Chemicals and Reagents
Plant Extraction, Fractionation, and Isolation
Water, n-hexane (95%), ethyl acetate (>99.7%), methanol
(>99.9%), and benzene-d6 (99.6% atom) were purchased from
Sigma–Aldrich. Chloroform (99%, stabilized with amylene),
acetic acid (glacial) analytical reagent grade were purchased from
Fisher Scientific. Formic acid 98% was purchased from Rectapur R©
VWR. Sephadex LH-20 was purchased from Sigma–Aldrich. TLC
Silica gel 60 F254, was purchased from Merck KGaG, 64271
Darmstadt.
Cell Culture
The following tumor cell lines were used: the PC-3 cell line
(ATCC Number: CRL-1435TM) was kindly provided by Dr.
Cyrill Bussy (Centre for Drug Delivery Research, UCL School
of Pharmacy, United Kingdom), the LNCaP clone FGC cell line
(ATCC Number: CRL-1740TM) was purchased from Sigma–
Aldrich, United Kingdom, and was obtained from the American
Type Culture Collection (ATCC). Human Dermal Fibroblasts,
adult (HDFa) catalog number C-013-5C was kindly provided
by Dr. George Pasparakis (Department of Pharmaceutics,
UCL School of Pharmacy). Antibiotic-antimycotic, penicillin-
streptomycin, trypsin-EDTA (0.25% trpysin, EDTA 4Na),
phosphate-buffered salines (PBSs), fetal bovine serum (FBS), and
Eagle’s Minimum Essential Medium (EMEM) were purchased
from GIBCO R©, United Kingdom (UK). RPMI 1640 with
L-glutamine was purchased from Lonza, United Kingdom.
All other chemicals were obtained from Sigma–Aldrich R©,
United Kingdom, unless stated otherwise.
Cell Viability Assays
Sulphorhodamine B (SRB) (3-[4,5-dimethylthiazol-2-yl]-2,5
diphenyl tetrazolium bromide) (MTT), trichloroacetic acid
(TCA), glacial acetic acid, 96% ethanol, isopropanol and tris base
were from Sigma–Aldrich.
Apoptosis Assays
Caspase-Glo R© 3/7 detection kit and DeadEndTM Fluorometric
TUNEL System were purchased from Promega. 4′,6-Diamidino-
2-phenylindole (DAPI) for nucleic acid staining was from
Sigma–Aldrich. Annexin-V FITC kit was from Miltenyi Biotec.
MitoProbeTM JC-1 Assay Kit was purchased from ThermoFisher
Scientific.
Cell Migration and Invasion Assay
OrisTM 96-well cell migration assay kit was from Platypus
Technologies and CytoSelect Cell Migration Assay kit was
purchased from Cell Biolab, Inc. CellTrackerTM Green was from
Life Technologies. Cytoselect 24-well cell invasion assay kit was
purchased from Cell Biolab, Inc.
Cell Cycle Analysis
Propidium iodide (PI) solution was purchased from Miltenyi
Biotec.
mRNA Gene Expression Assay
Oligonucleotide primers were custom-synthesized by
Primerdesign, Ltd. RNeasy R© Plus Mini, gDNA eliminator
spin column, and Omniscript R© Reverse Transcription kit were
purchased from Qiagen PrecisionFASTTM MasterMix with
SYBR Green was obtained from Primerdesign, Ltd. DMSO was
purchased from Sigma–Aldrich.
Plant Materials Extraction and
Fractionation
Certified dried plant materials of F. deltoidea var. angustifolia
(FD1) and F. deltoidea var. deltoidea (FD2) were obtained from
dedicated farms in Johor, Malaysia. Samples were processed using
a laboratory scale mill until fine powder was produced. Vouchers
for each herbal drug were deposited at the Institute of Bioproduct
Development. The air-dried and powdered parts of different
amount of plants (±50 g) were extracted with methanol for
72 h via a maceration process. The crude extracts were obtained
after the evaporation of the methanol to complete dryness under
reduced pressure at 40◦C. The crude methanol extract was re-
dissolved in 90% methanol and partitioned into n-hexane (FD1h,
FD2h) chloroform (FD1c, FD2c) and aqueous extracts (FD1a,
FD2a).
A sample (500 mg) of the crude chloroform extract
was suspended in 2 mL of absolute methanol and applied
onto a chromatographic column (2.3 cm × 40 cm) packed
with sephadex LH-20 (Sigma–Aldrich R©, United Kingdom)
and equilibrated with absolute methanol. The column was
exhaustively washed with absolute methanol at a flow rate of
60 mL/h. 6 mL fractions were collected using Retriever R© II
fraction collector. 140 fractions were collected for each plant
extracts.
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TLC Analysis
All fractions were examined by a thin layer chromatography
(TLC) methodology on silica gel plates (TLC Silica gel 60 F254,
Merck KGaG, 64271 Darmstadt) using (a) Chloroform-Methanol
(80:20, v/v) or (b) Toulene- Ethyl Acetate-Acetic Acid (80:18:2,
v/v/v) as mobile phase. The bands were visualized at white light,
254 and 366 nm wavelengths before and after derivatization with
anisaldehyde using CAMAG TLC Visualizer. Eluates were then
pooled into major fractions based on the TLC profiles. After
evaporation of methanol, the samples were left to air-dried and
residues weighed.
Microfraction Collection Using
HPLC-DAD (High Performance Liquid
Chromatography-Diode Array Detector)
High performance liquid chromatography-diode array detector
(HPLC-DAD) chromatograms were obtained on an Agilent 1200
series HPLC system (Agilent, United States). The stationary phase
was Agilent C18 column (250 mm × 4.6 mm id, 5 µm). The
microfractions were collected using Agilent 1200 series fraction
collector. The data was collected and processed with the Agilent
OpenLab CDS Chemstation Edition software (Agilent).
Ultra High Performance Liquid
Chromatography (UHPLC) and Mass
Spectrometry (MS) Analysis
The UV (200–500 nm) and ELSD profiles were acquired
to provide indication of the type of compound and a
quantitative estimation of each components presence in the active
fractions respectively. This was performed on Waters Acquity
UHPLC system consisted of Solvent Manager, Sample Manager,
Photodiode Array Detector (Waters, Milford, MA, United States)
and SEDEX Model 85 LT-ELSD detector (SEDERE, Olivet,
France). Data acquisition and processing was carried out using
Pro Empower 3 software (Waters, Milford, MA, United States).
The accurate mass measurement was acquired on Waters
Acquity UHPLC system coupled with a Waters Micromass LCT
Premier Time-of-Flight mass spectrometer (Waters, Milford,
MA, United States) and controlled by Mass Lynx 4.1 software.
Sample was ionized using electrospray ionization source which
was optimized as follows: capillary voltage 2400 V, cone voltage
40 V, dessolvation temperature 330◦C, source temperature 120◦C,
cone gas flow 20 L/h, dessolvation gas flow 700 L/h and
multichannel plate detector voltage at 2450 V. The mass accuracy
was calibrated for a mass range of 100–1000 using sodium
formate to a mass error < 2 ppm. Leucine-enkaphalin (0.25 ppm
with 0.1% formic acid) was used as internal reference and
infused through the LockSpray probe at a flowrate of 7 uL/min
using a dedicated LC pump (Shidmazu LC-10ADvp, Duisburg,
Germany). Two microliter of 5 mg/mL sample was injected in the
partial loop with needle overfill mode. The protocol for the UV,
ELSD, and MS profiling was established on a C18 column (Waters
Acquity UPLC BEH C18, 150 mm × 2.1 mm, 1.7 µm) that
was protected with a pre-column (Waters VanGuard BEH C18,
1.7 µm). Column and sample temperature was fixed at 40 and
10◦C respectively. The mobile phase consisted of water (solvent
A) and acetonitrile (solvent B), each containing 0.1% formic acid
(v/v). A generic 50 min gradient at a flowrate of 0.46 mL/min
was applied as follows: 0–30 min, 5–95% B; 30–40 min, 95%
B; 40–40.20 min, 95–5% B and end at 50 min isocratic step for
column equilibration to initial conditions. The acquired MS1 raw
data was converted to mzXml format using Proteowizard1 and
imported to an open source software, MzMine 2.112. Peak list was
generated using 2D GridMass, followed by deisotoped step and
peak alignment. Identification was performed based on a custom
database created from Dictionary of Natural Products (DNPs on
DVD, Windows 7 version 6.1).
Cells Culture
Both PC-3 and LNCaP cell lines were grown in a cell culture
flask (Nunc), surface area 75 cm2 and maintained in RPMI-
1640 (Roswell Park Memorial Institute medium) (Lonza, BE12-
702F) containing L-glutamine. The media was supplemented
with 10% of heat-inactivated FBS (Gibco R©, 10500-064) and 1%
penicillin-streptomycin antibiotics containing 10000 Units/ml of
penicillin and 10000 µg/ml streptomycin (Gibco R©, 15140-122)
to prevent bacterial growth. HDFa cell line was grown in a
cell culture flask (Nunc), surface area 75 cm2 and maintained
in DMEM (Dulbecco’s Modified Eagle Medium) containing
L-glutamine and high glucose (Gibco R© 11965092). The media
was supplemented with 10% of heat-inactivated FBS (Gibco R©,
10500-064), 1% 100X NEAA (non-essential amino acids, Gibco R©
11140035), and 0.1% of both 10 mg/mL Gentamicin solution
1000X (Gibco R© 15710049) and 250 ug/mL Amphotericin B
solution 1000X (Gibco R© 15290018) to prevent bacterial growth.
All cells were maintained at 37◦C in a humidified atmosphere of
5% CO2. The prepared media was used to grow and seed the cells
in a 96-well plate (NunclonTM) for cellular based assays and for
plant extracts as well as fractions dilution.
Cell Viability Assays
The SRB and MTT assays were performed as previously described
(Vichai and Kirtikara, 2006; Houghton et al., 2007).
Cells Morphology Analysis
PC3 and LNCaP cells were seeded in 12 well plates and left to
attach and proliferate for 48 h of incubation time. Then the plant
extracts were added, the morphology and the population of the
cells were monitored using an EVOS R© FL Imaging System at 24,
48, and 72 h.
Apoptosis Detection Assays
Caspases 3/7 Activity
In this study, the apoptosis induced by plant extracts was
determined by measuring the activity of caspases 3 and 7 using
an apoptosis detection kit (Promega, G8091). The Caspase-Glo R©
3/7 assay was performed according to the manufacturer’s protocol
with slight modifications. PC-3 and LNCaP cells were seeded in
96 well plate at 2.5 × 103. The cells were left for 24 h to allow
cells attachment. After 24 h the cells were treated with extracts,
1http://proteowizard.sourceforge.net/tools.shtml
2http://sourceforge.net/projects/mzmine/
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fractions, vehicle control (DMSO), Paclitaxel and a blank (cell-
free medium) for 48 h. 100 µl of Caspase-Glo R© 3/7 reagent was
added to each wells after 48 h incubation period and mixed
gently for 30 s. Then, the plate was incubated for 1 h at room
temperature. After the completion of the incubation period,
the luminescence of each plant extracts was measured using a
plate-reading luminometer (Tecan Infinite R© M200). The assay
was performed independently in triplicate and the results were
calculated using the following equation:
RLU = Luminescence (samples) − Luminescence (blank)
Annexin V-FITC and Propidium Iodide Staining
PC3 and LNCaP cells were seeded in 12 well plates and incubated
for 48 h. After incubation, plant extracts and Paclitaxel (positive
control) were added and further incubated for 6 h at 37◦C in
a 5% CO2 atmosphere. The cells were then washed with PBS
and detached with 0.25% Trypsin-EDTA solution. The cells were
then resuspended in 100 µL of 1X binding buffer and 10 µL of
Annexin V-FITC were added. The mixture was mix carefully and
incubated for 15 min in the dark at room temperature. After
15 min, the cells were washed again with 1 mL of 1X binding
buffer and centrifuged at 300 × g for 10 min. Subsequently,
the cells were resuspended in 500 µL of 1X binding buffer and
PI solution were added prior to flowcytometry (MACSQuant R©
Analyzer 10) analysis.
Determination of Mitochondrial Membrane Potential
(MMP)
The change in mitochondrial transmembrane potential (1ψm)
induced by the active extracts of the plants in prostate cancer
cell line (PC3) was determined by using flowcytometry technique
with the appropriate fluorescent probe known as JC-1 (Isenberg
and Klaunig, 2000). 1 × 106 cells/ml of PC3 was seeded into 6
well plate and incubated for 48 h. After incubation, plant extracts
and CCCP (positive control) were added and further incubated
for 6 h at 37◦C in a 5% CO2 atmosphere. The treated cells were
then labeled with 2 µM of JC-1 for 15 min at 37◦C and washed
with warm PBS. The cells were analyzed on a flowcytometer
(MACSQuant R© Analyzer 10) with 488 nm with 530- and 585-nm
pass emission filters. CCCP-treated cells (10 µM) were taken as
positive controls.
Terminal Deoxynucleotidyl Transferase-Mediated
Biotin dUTP Nick End Labeling Assay
Apoptotic cells were detected by using a technique called an
in situ end labeling of the 3′-OH end of the DNA fragments
generated by apoptosis-associated endonucleases. This was
analyzed using the Dead End apoptosis detection kit (dUTP Nick
End Labeling, TUNEL assay) acquired from Promega (Madison,
WI, United States). Prostate cancer cells were grown in LabTek II
chamber slide and treated with plant extracts for 72 h. The cells
were then washed in PBS and 4% paraformaldehyde solution was
used as fixation agent by immersing the slides in the solution for
25 min. All the steps were performed at room temperature, unless
otherwise specified. Following the fixation step, the cells were
then washed twice by immersing them in fresh PBS for 5 min.
Cells were permeabilised using 0.1% Triton X-100 solution in PBS
for 5 min, washed twice in PBS, and then covered with 100 µL of
equilibration buffer and kept for 5–10 min. The equilibrated areas
were blotted around with tissue paper, and 50 µL of terminal
deoxynucleotidyl transferase (TdT) reaction mix was added to the
sections on the slide and were then incubated at 37◦C for 60 min
inside a humidified chamber for the end-labeling reaction to
occur. The slides were then immediately immersed in 2X sodium
chloride–sodium citrate buffer for 15 min in order to terminate
the reactions. Following that step, all slides were washed three
times by immersing them in fresh PBS for 5 min to remove
unincorporated biotinylated nucleotides. The slides were then
immersed in a freshly prepared 1 µg/mL PI solution for 15 min
at room temperature in the dark. The washing procedure was
repeated after 15 min and then the slides were immediately
analyze under a fluorescence microscope (EVOS R© FL Imaging
System) using a standard fluorescein filter set to view the green
fluorescein at 520 ± 20 nm and the red fluorescence of PI at
620 nm.
In Vitro Cell Migration Assay
OrisTM96-Well 2D Cell Migration Assay
The in vitro cell migration was determined by using the OrisTM
96-well cell migration assay kit (Platypus Technologies) following
the manufacturer’s instruction. 5 × 104 of PC3 cells were seeded
in each well and left for 24 h. The stoppers that were used to
create the migration zone were removed after 24 h and the cells
were washed with PBS to remove any unattached cells. 100 µL of
fresh media with or without the plant extracts were added to each
well. The cells were allowed to migrate into the migration zone
for 72 h. Cells were fluorescently stained with CellTrackerTM
Green (Life Technologies). The seeded plate was incubated in
a humidified chamber for 72 h and at various time points (24,
48, and 72 h), the fluorescent signals in the detection zone were
measured using a microplate reader (SynergyTM HT, BioTek)
with 492 nm excitation and 517 nm emission filters.
Boyden Chamber 3D Migration Assay
The cell migration study was also analyzed using the CytoSelect
Cell Migration Assay kit (Catalogue number CBA-100-C
purchased from Cell Biolab, Inc.) (Ridley et al., 2003). This kit
contains polycarbonate membrane inserts (8 µm pore size) in
a 24-well plate. Under sterile conditions, the 24-well migration
plate was allowed to warm up to room temperature for 10 min.
Cell suspension containing 1.0 × 106 cells/ml in serum-free
media was prepared. Fresh media (control) and media with
respected plant extracts, were added directly to individual
transwell inserts with the cell suspension. Overnight serum
starvation had been performed prior to running the assay. 500µL
of media containing 10% FBS was added to the lower well of the
migration plate and 300 µL of the cell suspension solution was
added to the inside of each insert and then incubated for 24 h in
a cell culture incubator. After 24 h incubation, the media were
carefully aspirated from the inside of the transwell insert. The
interior part of the inserts was washed with wet cotton swab in
order to remove non-migratory cells. The inserts were transferred
to a clean well containing 400 µL of Cell Stain Solution (Crystal
Violet dye) and incubated for 10 min at room temperature. Then,
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the inserts were gently washed in a beaker of water and left to air
dry. Each inserts were transferred into wells containing 200 µL
of Extraction Solution (10% acetic acid), incubated for 10 min at
room temperature on an orbital shaker. 100 µL of each sample
was transferred to a 96-well plate and was measured at 560 nm by
using a microtiter plate reader (Tecan Infinite R© M200).
In Vitro 3D Cell Invasion Assay
The cell invasion was measured using a Cytoselect 24-well cell
invasion assay kit (Catalogue number CBA-100-C purchased
from Cell Biolabs, Inc.). This kit included polycarbonate
membrane inserts (8-µm pore size). The upper surface of the
insert membrane was coated with a protein matrix isolated from
Engelbreth-Holm-Swarm tumor cells. Basement membranes of
Boyden chambers were rehydrated with 300 µL serum-free
media, and 1 × 106 cells were then seeded into the upper area
of the chamber in serum-free media (control) with or without the
plant extracts. Overnight serum starvation had been performed
prior to running the assay. 500 µL of media containing 10%
FBS was added to the lower well of the migration plate. After
incubation for 48 h, the non-invading cells on the upper surface
of the inserts were removed with a cotton swab and invading cells
on the lower surface were stained with crystal violet Cell Stain
Solution and incubated for 10 min at room temperature. Then,
the inserts were gently washed in a beaker of water and left to air
dry. Each inserts were transferred into wells containing 200 µL
of Extraction Solution (10% acetic acid), incubated for 10 min at
room temperature on an orbital shaker. 100 µL of each sample
was transferred to a 96-well plate and was measured at 560 nm by
using a microtiter plate reader (Tecan Infinite R© M200).
Cell Cycle Distribution Study
PC3 and LNCaP cells were seeded in 6 well plates and incubated
for 48 h. Plant extracts and Paclitaxel (positive control) were
added after 48 h, and the cells were further incubated for 48 h
at 37◦C in a 5% CO2 atmosphere. The cells were then washed
and trypsinized with 0.25% Trypsin-EDTA solution for cells
detachment. Cell pellet were resuspended in 1 mL PBS and
washed twice by adding 10 mL PBS. After that the cells were
centrifuged at 300 × g for 10 min at 4◦C. Once the supernatant
was removed, 1 mL of ice-cold 70% ethanol was slowly added
drop by drop to the cell pellet. The cells were allowed to fix
in ethanol for 18 h. After 18 h, the cells were centrifuged at
500 × g for 10 min at 4◦C. The supernatant was removed
and 1 mL of staining solution containing 1 mg/mL PI and
100 Kunitz units/mL of RNase A were added to the cells and
incubated for 30 min before being analyzed using flowcytometry
(MACSQuant R© Analyzer 10).
Real-Time RT-qPCR Analysis
mRNA Extraction and cDNA Synthesis
After exposing PC3 cells (5 × 105 cells/well) to plant extracts,
fractions and DMSO 1% for 96 h, total RNA was extracted using
RNeasy R© Plus Mini (Qiagen) according to the manufacturer’s
protocol. Samples were treated with gDNA eliminator spin
column (Qiagen) to avoid genomic DNA contamination. The
quantity and quality of RNA was determined by differential
readings at 260 and 280 nm wavelength using Nanodrop 2000
(Thermo Scientific). The integrity of total RNA from PC3 cells
was assessed by visual inspection of the two rRNAs 28 and 18 s
on agarose gels. cDNA was synthesized from 1µg of total RNA by
using Omniscript R© Reverse Transcription kit (Qiagen) according
to the manufacturer’s instruction in a final volume of 20 µL.
RT-qPCR Conditions and Analysis
Sequence for the primers used in this study are listed in
Table 1. All primers used in this study were designed and
obtained from Primerdesign, Ltd. The RT-qPCR was carried
out in 96-well plates using a PikoRealTM Real-Time PCR
detection System (Thermo Fisher Scientific). Each well contained
a final reaction volume of 20 µL (10 µL of PrecisionFASTTM
MasterMix with SYBR Green, 5 µL of cDNA template diluted
appropriately, 1 µL of resuspended primer mix at a final
concentration of 300 nM and 4 µL of RNase/DNase free
distilled water). PCR reaction was performed using the following
conditions: initial denaturation at 95◦C for 2 min, then 40
cycles of denaturation at 95◦C for 15 s, corresponding annealing
temperature of each genes as listed in Table 1 for 30 s and
extension at 72◦C for 30 s. At the end of the run, heating
the amplicon from 60 to 95◦C in order to confirm the
specificity of the amplification for each primer pair generated
a melting curve. All RT-qPCR were run in quadruplicates.
Standard curves were produced to check the PCR efficiency
using a fivefold dilution series of cDNA. Efficiency (E) of
primer pairs was obtained from the slope of the calibration
curve generated. The relative expression was calculated on the
basis of ‘delta delta Ct’ (11Ct) values. Normalization of the
target genes was achieved by using GAPDH as a reference
gene.
Statistical Analysis
Data collected and reported in this study is expressed as a
mean ± standard deviation. Statistical analysis of the data was
TABLE 1 | Sequence of primers used in RT-qPCR analysis.
Gene Primer sequences Annealing
temperature (◦C)
GAPDH Sense: 5′-ATGCTGGCGCTGAGTACGTC-3′
Anti-sense: 5′-GGGCAGAGAGATGATGACCCTT-3′
55
BAX Sense: 5′-ATGGAGCTGCAGAGGATGAT-3′
Anti-sense: 5′-CAGTTGAAGTTGCCGTCAGA-3′
56.5
BCL-2 Sense: 5′-GAGGTCACGGGGGCTAATT-3′
Anti-sense: 5′-GAGGCTGGGCACATTTACTG-3′
56.8
VEGFA Sense: 5′-TGCTCTACTTCCCCAAATCACT-3′
Anti-sense: 5′-CTCTCTGACCCCGTCTCTCT-3′
57.6
Smac/
DIABLO
Sense: 5′-GCACAGAAATCAGAGCCTCATT-3′
Anti-sense: 5′-TTCAATCAACGCATATGTGGTCT-3′
56.4
CXCR4 Sense: 5′-CCAAAGAAGGATATAATGAAGTCACT-3′
Anti-sense: 5′-GGGCTAAGGGCACAAGAGA-3′
56.4
CXCL12 Sense: 5′-CTCCTCTTTCAACCTCAGTGATT-3′
Anti-sense: 5′-GAGAAGCAGAAGCAAGATTAAGC-3′
56.8
ALOX5 Sense: 5′-AAGCGATGGAGAACCTGTTCA-3′
Anti-sense: 5′-GTCTTCCTGCCAGTGATTCATG-3′
56.8
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FIGURE 1 | Morphological changes of (A) PC3 and (B) LNCaP cells treated with the IC50 of the plant extracts and paclitaxel (positive control) for 24, 48, and 72 h
viewed under the EVOS R© FL Imaging System (100x magnification). Reduced in cell population was noted after 24, 48, and 72 h of treatment as compared to the
control (untreated cells).
carried out using the GraphPad Instat version 3 (GraphPad
Software, Inc., La Jolla, CA, United States). The values of P< 0.05
were considered to be statistically significant. All experiments
were conducted three times independently in triplicate. The
Inhibitory concentration 50 (IC50) values were taken from
the minimal experimental concentration showing 50% cell
death and calculated using GraphPad Prism 5. Each samples
was compared to the control group with GraphPad by using
the Student’s t-test to determine any significant effect of the
samples.
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FIGURE 2 | (A) PC3 and (B) LNCaP cells viewed under the EVOS R© FL Imaging System (200x magnification) after 72 h of treatment with the IC50 concentration of
the plant extracts and paclitaxel (positive control). The cells showed characteristics of apoptosis such as the formation of apoptotic bodies (AB), membrane blebbing
(MB), and nuclear compaction (NC).
RESULTS
Yield of the Plant Extracts
The yield of the plant extracts were; FD1c = 0.96%,
FD1h = 0.27%, FD1a = 13.18%, FD2c = 0.65%, FD2h = 0.22%,
FD2a= 13.10% (all in dry w/w).
Cell Viability
FD1c and FD2c were the most cytotoxic extracts against both
prostate cancer cell lines with IC values of 23 and 29 µg/mL
respectively for PC3 and 19 and 23 µg/mL respectively for
LNCaP.
Cell Morphology
In this study, the morphological changes of the prostate
cancer cell lines untreated and treated with the active
extracts of F. deltoidea L. were observed using an EVOS R©
FL Imaging System at 24, 48, and 72 h. The characteristics
of apoptosis such as cells detachment from the substratum,
cell shrinkage, nuclear condensation, membrane blebbing
and the formation of apoptotic bodies were detected
in the treated cells (Figures 1, 2). The reduction in
the cell numbers is obvious in the treated populations
(Figure 1).
Pro-apoptotic Effect of the Active
Extracts of Ficus deltoidea Plant
Stimulation of Caspases 3/7 Activity
Both LNCaP and PC3 (Figure 3) cells treated with FD1c and
FD2c extracts showed significance increase (P < 0.01) in the
activity of caspases 3 and 7 when compared to the untreated cells.
Detection of Apoptotic Cells Using Annexin-V FITC
Staining
The results summarized in Figure 4 show that there
was a significant increase (P < 0.05) of the population
of LNCaP cells in the early apoptosis phase after
treatment with F. deltoidea chloroform extract (FD1c:
35%, FD2c: 16%) when compared to the untreated cells
(11%). PC3 cells showed a similar trend (FD1c: 29%,
FD2c:13%) (P < 0.05) when compared to the untreated
cells (7%).
MMP Depolarization in PC3 Cell Line Treated with the
Active Plant Extracts
Mitochondrial changes, including variations in mitochondrial
membrane potential (MMP) (1ψm), are the key events
during drug-mediated apoptosis (Zamzami et al., 1995). One
of the distinctive features of the early stage of apoptosis is
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FIGURE 3 | Caspase 3/7 activity in (A) PC3 and (B) LNCaP cells treated with
the active extracts of Ficus deltoidea L. for 72 h. The y-axis shows the
luminescent signal subtracted from a blank, which is proportional to the
caspases activity. The error bars display the standard error of mean (SEM)
obtained from three independent experiments. Significance compared to
control, ∗P < 0.05, ∗∗P < 0.01 as determined by un-paired t-test.
the disruption of mitochondria functionality, which includes
changes in the MMP and alterations to the oxidation-reduction
potential of the mitochondria. Figure 5 shows that both FD1c
and FD2c increased the percentage of MMP depolarization
significantly in PC3 cell lines. This could suggest that the
active plant extracts induce cell death in human prostate
cancer cells with the involvement of mitochondrial membrane
depolarization.
Nuclear DNA Fragmentation
Figure 6 shows that after 72 h treatment with active plant
extracts, more localized green fluorescence (fluorescein-12-
dUTP) color can be detected in the PC3-treated cells as
compared to the control (untreated cells). The localized green
fluorescence label can only be detected in apoptotic cells
while the red PI stain will label both apoptotic and non-
apoptotic cells. These findings provide more evidence that
both FD1c and FD2c induce prostate cancer cell death via
apoptosis.
FIGURE 4 | The dot plots (A) and the percentage (%) of cell distribution (B) of
LNCaP cells and the dot plots (C) and the percentage (%) of cell distribution
(D) of PC3 cells after 6 h treatment with the active extracts of F. deltoidea L.
as determined by Annexin V-FITC and PI staining. The cells were treated with
different active extracts for 6 h. ∗P < 0.05 as compared to the untreated cells.
Results shown are representative of three independent experiments.
Modulation of Apoptotic-Related mRNA Gene
Expressions
Results in Figure 7 show that FD1c and FD2c were able to
increase the expression of Bax (FD1c: twofold, FD2c: twofold)
and Smac/DIABLO (FD1c: fourfold, FD2c: twofold) in a
significant manner. Both FD1c and FD2c also significantly down-
regulated the expression of Bcl-2 by 7 and 12-fold respectively.
However, no significant effect was observed for both FD1c and
FD2c for the expression of ALOX5 gene, which codes for the
5-LOX protein (Data presented as Supplementary Materials).
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FIGURE 5 | Depolarization of mitochondrial membrane potential (MMP) of PC3 prostate cancer cell lines was induced by the active extracts of F. deltoidea L. PC3
cell lines were treated with the IC50 of FD1c and FD2c for 6 h. (A) Representative MMP profiles of flow cytometry for active plant extracts-treated PC3 cells.
(B) Quantification analysis of percentage MMP intensity in (A). Data means ± SEMs (n = 3). ∗P < 0.05, ∗∗P < 0.01 and against control.
FIGURE 6 | PC3 cells treated with FD1c and FD2c extracts and DNAse
(positive control) and stained with DeadEndTM Flurometric TUNEL system
after 72 h. Red fluorescence indicated healthy cells while green fluorescence
showed fragmented nuclear DNA.
5-LOX expression and activity are fundamental for PC3 survival
(Ghosh and Myers, 1997; Werz and Steinhilber, 2006). These
findings suggest that both FD1c and FD2c increase the expression
FIGURE 7 | (a) Bax, (b) Bcl-2, (c) Smac/DIABLO mRNA gene expressions in
PC3 cells treated with MNTC of FD1c and FD2c after 96 h. The genes
expressions were determined as described in RT-qPCR Conditions and
Analysis. Data are mean ± SD; n = 4 experiments. ∗P < 0.05, ∗∗∗P < 0.001.
of pro-apoptotic genes and reduce the expression of anti-
apoptotic genes, which could lead to the increased production
of pro-apoptotic proteins and reduced production of anti-
apoptotic proteins and ultimately inducing PC3 cells death via
apoptosis.
Cell Cycle Arrest at G2M Phase
There was a significant increase (P < 0.05) in the population of
PC3 cells at the G2M phase as compared to the untreated cells
when treated with the IC50 of both FD1c and FD2c extracts
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FIGURE 8 | Effect of the active extracts of F. deltoidea L. on the cell cycle of (A) PC3 and (B) LNCaP cells analyzed by measuring DNA content using flow cytometer.
The cells were treated with the IC50 of the active extracts. ∗P < 0.05 as compared to the untreated cells. Paclitaxel treatment was used as positive control. Results
shown are representatives of three independent experiments.
(Figure 8A). The same trend was observed when the LNCaP cells
were treated with the IC50 of both FD1c and FD2c (Figure 8B).
In addition, treatment with the IC50 of both plant extracts also
cause a significant (P < 0.05) decrease in the population of both
LNCaP and PC3 cells at G0/G1 phase while the percentages of cell
population at the S phase remains almost the same for both cell
lines.
Inhibition of PC3 Cells Migration
Figure 9A indicates that both FD1c and FD2c extracts at
MNTC concentration significantly inhibited the migration of
PC3 cells. This observation also suggests that both FD1c and
FD2c suppressed the migration of PC3 cells in a time-dependent
manner. FD1c reduced the number of migrated cells by 50% at
every time point. To further validate the results of this study,
another migration study was conducted by using the trans-well
migration assay method (Boyden Chamber). Results obtained
from this experiment are shown in Figure 9B. After 24 h of
treatment with FD1c and FD2c, the number of migrated PC3 cells
has reduced significantly by almost 60% (FD1c) and 50% (FD2c).
Thus, it seems quite likely that FD1c and FD2c, could inhibit PC3
cells migration.
Frontiers in Pharmacology | www.frontiersin.org 11 December 2017 | Volume 8 | Article 895
fphar-08-00895 December 14, 2017 Time: 11:46 # 12
Hanafi et al. Ficus deltoidea Effect on PC3
FIGURE 9 | (A) OrisTMCell Migration analysis: 5 × 104 of PC3 cells were seeded per well and allowed to adhere. Stoppers were then removed and both FD1c and
FD2c were added to the wells, and the plate was incubated to permit cell migration. The cells were labeled with CellTrackerTM Green and the fluorescence quantified
in the detection zone using a Synergy HT BioTek plate reader. (B) CytoSelect Cell Migration analysis: effects of both FD1c and FD2c on the migration of the PC3
cells. PC3 cells were treated with the MNTC concentration of FD1c and FD2c, for 24 h. Results shown are representatives of three independent experiments,
∗P < 0.05, ∗∗P < 0.01 and against control as analyzed by the Student’s t-test.
Inhibition of PC3 Cells Invasion
Figure 10 shows the effect of both FD1c and FD2c on PC3 cells
invasion after 48 h of treatment. Both active extracts exhibited
significant inhibition on the invasion of the prostate cancer
cells after 48 h of treatment. FDIc extract reduces the number
of invading PC3 cells by almost threefolds while FD2c extract
reduces the number of the invading PC3 cells by almost
twofolds in a significant manner when compared to control
(P < 0.05). These results indicate that both FD1c and FD2c
are not only capable of inhibiting or delaying PC3 cells
migration but could also prevent cells invasion in a very
significant way.
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FIGURE 10 | CytoSelect cell invasion analysis: effects of both FD1c and FD2c
on the invasion of the PC3 cells. PC3 cells were treated with the MNTC
concentration of FD1c and FD2c for 48 h. Results shown are representatives
of three independent experiments, ∗P < 0.05, ∗∗P < 0.01 and against control
as analyzed by the Student’s t-test.
TABLE 2 | mRNA gene expression analysis (CXCR4, CXCL12, and VEGF-A) in
PC3 cells treated with MNTC of the active plant extracts of Ficus deltoidea after
96 h.
Sample Gene Fold expressions relative to Control in PC3 cells
FD1c CXCR4 2∗
CXCL12 0.01∗∗∗ (>20-fold)
VEGF 0.1∗∗∗ (ninefold)
FD2c CXCR4 1
CXCL12 0.003∗∗∗ (>20-fold)
VEGF 1
The genes expressions were determined as described in RT-qPCR conditions and
analysis where Control = 1. Data are mean ± SD; n = 4 experiments. ∗P < 0.05,
∗∗∗P < 0.001.
Modulation of Migration and
Invasion-Related mRNA Gene
Expression
Both FD1c and FD2c inhibit the mRNA gene expression of
CXCL12 (Table 2) in a significant manner. Both FD1c and
FD2c extracts reduce the expression of CXCL12 by more than
20-folds. However, only FD1c was able to increase the expression
of CXCR4 by twofold significantly. FD1c down-regulates the
expression of VEGF by ninefolds whereas FD2c did not show any
significant effect on the mRNA gene expression. The significant
inhibition of the mRNA gene expression of CXCL12 by both
FD1c and FD2c and the inhibition of CXCR-4 and VEGF-A by
FD1c might suggest an explanation on how these plant extracts
were able to suppress both migration and invasion as reported
earlier.
Bioguided Isolation of the Active Fraction
FD1c and FD2c were chosen for further fractionation based
on the IC50 values. 140 fractions were collected for each plant
extracts and each fractions were examined by a TLC. Based
on the TLC profiles of FD1c and FD2c (Data presented as
Supplementary Materials) the eluates were then pooled into
13 major fractions (FD1c: fractions 20–23, fractions 24–30,
fractions 31–36, fractions 37–42, fractions 43–51, FD2c: fraction
16, fractions 17–22, fractions 23–26, fractions 27–28, fractions
29–33, fractions 34–36, fractions 37–39, fractions 40–45). These
fractions were subjected to another cytotoxicity study with
PC3 cell lines to determine their activity. Three fractions
were observed to have better efficacy than their respective
plant extracts as their IC50 values for each fractions were
significantly lower than their respective plant extracts before
further fractionation process being done (P < 0.05). These
fractions were FD1c F43-51, FD2c F29-33, and FD2c F34-36.
The UHPLC-MS-ELSD-PDA profiles are shown in Figure 11A.
The shifts for the retention time (tR) of the 12 peaks in this
chromatogram are due to the sequential four-channel detection
system. The universal ELSD detection method provides accurate
data in accessing the relative content of individual compounds
in a mixture that may not be UV active (Yang et al., 2014).
Peaks 3a and 3b with tR 5.72 min were present in the highest
concentration, which accounts for 75.27% of the total mass. The
positive and negative-ion ESIMS detection procedures showed
different sensitivities (see Table 3A), with the positive mode
producing a strong total ion chromatogram (TIC) for all the
compounds. Therefore, the positive ESIMS and UV data were
used to determine the structural information of the compounds
present. Peaks 3a and 3b gave the same accurate mass of 433
and were dereplicated as Vitexin and Isovitexin respectively.
These two compounds are known constituents of F. deltoidea
(Bunawan et al., 2014). Peak 5 with tR 9.46 min was also
detected with a good concentration with 8.22% of total mass and
it was dereplicated as Brosimacutin. The other 10 compounds
(Compounds 1, 2, 4, and 6–12) were present in a very small
concentration and thus not considered to play a major role in
the cytotoxic activity of FD1c F43-51 fraction. FD2c F29-33 and
FD2c F34-36 were active against PC3 cancer cell lines with IC50
values of 28 and 24 µg/mL respectively. The UHPLC-MS-ELSD-
PDA chromatogram in Figure 11B shows six peaks. For FD2c
F29-33, four major peaks were detected – peak 1 is similar to peak
3 – at tR 24.15 (peak 2), tR 24.42 (peak 3), tR 25.87 (peak 4), and
tR 31.59 (peak 6). These peaks correspond to 21.07% (peak 3 +
peak 1), 20.09% (peak 2), 34.40% (peak 4), and 31.59% (peak 6)
of total mass respectively. ESIMS data shows that these peaks gave
accurate masses of 457, 425, 427, and 443 respectively and were
dereplicated as Oleanolic acid, Lupenone, Lupeol, Moretenol, and
Betulin. For FD2c F34-36 fraction, two major compounds were
dereplicated as Oleanolic acid – at tR 24.42, which correspond
to 73.33% (peak 1 + peak 3) of total mass – and Lupenone
at tR 24.15, and tR 27.77 – which correspond to 18.65% of
total mass. Both Oleanolic acid and Lupenone gave accurate
masses of 457 and 425 respectively according to the ESIMS data
(see Table 3B).
Modulation of mRNA Gene Expression
by the Active Fractions
Apoptosis-Related Genes Expression
FD2c F29-33 and FD2c F34-36 significantly inhibited
Smac/DIABLO mRNA gene expression by five and five folds
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FIGURE 11 | Overlay of ELSD, UV, and MS (base peaks monitoring) chromatograms for samples (A) FD1c F43-51 and (B) FD2c F29-33, FD2c F34-36.
respectively. However, FD1c F43-51 did not show any significant
effect on the expression of Smac/DIABLO. Therefore, these
data suggest that the active fractions of the plant extracts (FD2c
F29-33, and FD2c F34-36) also induced PC3 prostate cancer cells
death via apoptosis as observed with their active extracts.
Migration-Related Genes Expression
Table 4 shows that FD1c F43-51 has significantly down-regulated
the mRNA gene expression of VEGF by fourfold, whereas both
active fractions of the FD2c (FD2c F29-33 and FD2c F34-36)
extract did not cause any significant changes to the expression
of VEGF. Even though none of the active fractions significantly
caused any changes to the expression of CXCR4, all 3 of them
had caused significant inhibition to the expression of CXCL12
by more than 20-fold. These findings are similar to the previous
results observed with the active extracts of the plants but with
greater efficacy. Therefore, the active fractions of the plant
extracts also inhibit PC3 prostate cancer cells migration and
invasion through similar mode of action.
Chromatographic and Mass Spectrometry Analysis
MS1 dereplication is one of the first approaches in structural
identification that is a common practice before MS/MS
dereplication and isolation work (Alali and Tawaha, 2009). It is
established by generating molecular formula from the accurate
mass data and comparing it with a bibliographical database
such as DNP, Universal Natural Products Database (UNPD),
and MarinLit. In this study, the custom database was created
from DNP by using three taxonomy filters; species, family, and
type of organism (Ficus 272 hits; Moraceae: 1,607 hits; Dicot:
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107,953 hits). In addition, the type of compound indicated by
the UV spectrum data was further used to reduce the number
of proposed identification and improve the accuracy of the
proposed identification. As an initial attempt to investigate the
composition of the active extracts, focus was given only to
components that gave a reasonable ELSD signal (quantitative
estimate). The corresponded mass spectrometry detection with
the ELSD signals for var. angustifolia and var. deltoidea are shown
in Figures 11A,B, respectively. The two active fractions from
var. deltoidea seemed to be similar in composition. Tables 3A,B
showed the dereplication results and ideally, whenever available,
structural identifications were confirmed by co-chromatography
with commercially available standards or compounds isolated in
the lab. The var. angustifolia primarily consisted of flavonoid
glycosides, furanocoumarin and chlorophylls derivatives while
var. deltoidea could be characterized by triterpenoids.
Anti-proliferative Activity of Dereplicated
Compounds
Previously, LC–MS dereplication has identified isovitexin in the
active fraction of FD1c and oleanolic acid, betulin, and lupeol
in the active fractions of FD2c. This study was conducted to
evaluate the cytotoxic activity of the individual compounds
identified through LC–MS dereplication method. SRB staining
assay was used for the purpose of this study. LC–MS dereplication
has identified isovitexin as one of the major compound in
the active fraction of FD1c, however the IC50 value for
isovitexin (IC50 = 43 µg/ml) is significantly (P < 0.05) higher
than its respective active fraction (IC50 = 12 µg/ml). Similar
findings were observed with the IC50 values for oleanolic acid
(IC50 = 34 µg/ml), botulin (IC50 = 47 µg/ml), and lupeol
(IC50 = 36 µg/ml), which were identified through LC–MS
dereplication of the active fractions of FD2c. The IC50 values
for each of these compounds were significantly (P < 0.05) higher
than their respective active fractions (FD2c F29-33 = 28 µg/ml,
FD2c F34-36= 24 µg/ml). These results indicated that the active
fractions of both FD1c and FD2c were more cytotoxic against
PC3 cells than each of these individual compounds. In the case
of FD1c, even though isovitexin was identified as the major
compounds in the active fraction, lower cytotoxic activity of the
compound against PC3 cells might suggest that the other minor
compounds such as brosimacutin and phaeoporphyrin might
have contributed to the more potent cytotoxic activity of the
active fraction. In the active fractions of FD2c, oleanolic acid,
betulin, and lupeol were dereplicated as the major compounds
in the active fraction. However, as mentioned earlier, none of
these individual compounds were shown to have better cytotoxic
activity than their respective active fractions. Once again, this
could suggest that the more potent cytotoxic activity of the active
fractions of FD2c might be due to the additives or synergistic
effects of the compounds identified in the plant.
Differential Cytotoxicity in Human
Dermal Fibroblasts Cells (HDFa)
This study is carried out in order to investigate the effect of the
active plant extracts on normal human cells. We established the
Maximum Non-Toxic Concentrations of the extracts (MNTC)
as the concentration allowing 80% of the cell population to
grow. The three active fractions, FD1c F43-51, FD2c F29-
33, and FD2c F34-36 were observed to have MNTC value of
more than 200 µg/mL. This information indicates that all the
active fractions of the plant show good selectivity and are only
specific in inhibiting prostate cancer cell lines (Data presented as
Supplementary Materials).
DISCUSSION
Two different cell lines have been used in this study (PC3 and
LNCaP) as each cell line represent different stage of prostate
cancer, the androgen-dependent and the androgen-independent
prostate cancer, respectively (Shafi et al., 2013). From our
investigations, all active plant extracts and their respective
fractions were cytotoxic against both types of prostate cancer cell
lines with lower IC50 values for PC3.
According to recent statistics provided by the Office for
National Statistics (2016), approximately 90% of androgen-
dependent prostate cancer are detected in the local and regional
stages, therefore the cure rate is very high as nearly 100% of
men diagnosed and treated at this stage will be disease free after
5 years. However, many men die as therapy eventually fails when
the disease progresses to androgen-independent stage (Feldman
and Feldman, 2001). This stage of prostate cancer is lethal and
has the ability to progress and metastasize. At present, there is
no effective therapy that can be used for men diagnosed with
androgen independent prostate cancer.
Therefore, we turned our main focus to investigate the effect
of the active plant extracts on PC3 cells. The active plant
extracts induce apoptosis in PC3 cells via the intrinsic pathway,
as evidenced by the significant activation of caspases 3 and 7.
This activation is mediated -at least in part- by their ability
to affect the gene expression of proteins such as Bcl-2, and
Smac/DIABLO. Smac/DIABLO is a novel mitochondria-derived
pro-apoptotic protein that plays an important role in sensitizing
tumor cells to die by apoptosis (Du et al., 2000; Verhagen
et al., 2000). It has a pro-apoptotic effect that is mediated by its
interaction with inhibitor of apoptosis proteins (IAPs) and the
release of effector caspases from them. The IAP protein family
that includes XIAP, c-IAP1 and c-IAP2 blocks both intrinsic and
extrinsic apoptotic pathways by binding to and inhibiting active
caspases, thus stopping the caspase cascade (Jia et al., 2003).
Smac/DIABLO functions by neutralizing the caspase-inhibitory
properties of XIAP (Ekert et al., 2001). This is achieved by
the displacement of XIAP from caspase 9 by Smac/DIABLO,
thus overcoming the ability of XIAP to repress the activity
of effector caspase, caspase-9, within the apoptosome complex
(Srinivasula et al., 2001). Carson et al. (2002) have shown that
Smac/DIABLO is required for mitochondrial-driven apoptosis
in human multiple myeloma and prostate cancer cells. Smac
peptide was also reported to enhance apoptosis induced chemo
or immunotherapeutic agents in the leukemic Jurkat cell line
(Guo et al., 2002), and in malignant glioma cells in vivo (Fulda
et al., 2002). Therefore, these findings prompted scientists to
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TABLE 4 | mRNA gene expression analysis (VEGF-A, CXCR4, and CXCL12) in
PC3 cells treated with MNTC of the active fractions of Ficus deltoidea after 96 h
(migration-related genes).
Sample Gene Fold expressions relative to Control in PC3 cells
FD1c F43-51 VEGF-A 0.3∗∗∗ (fourfold)
CXCR4 1
CXCL12 0.02∗ (>20-fold)
FD2c F29-33 VEGF-A 1
CXCR4 1
CXCL12 0.005∗∗∗ (>20-fold)
FD2c F34-36 VEGF-A 1
CXCR4 2
CXCL12 0.005∗∗∗ (>20-fold)
The genes expressions were determined as described in RT-qPCR conditions and
analysis where Control = 1. Data are mean ± SD; n = 4 experiments. ∗P < 0.05,
∗∗∗P < 0.001.
develop or find small molecules that could mimic the functions
of Smac/DIABLO as therapeutic agents to induce cancer cells
death or increase the apoptotic effects of the chemotherapeutic
agents. This study shows that both active plant extracts (FD1c
and FD2c) were able to significantly increase the expression of
Smac/DIABLO gene in PC3 cells, thus contributing -in part- in
activating the intrinsic pathway of apoptosis. However, upon
further fractionation of the active extracts, the active fraction
of FD1c (FD1c F43-51) did not show any significant effect on
the expression of Smac/DIABLO. This could happen due to
the loss of active metabolite/s during the fractionation process.
Even though FD1c F43-51 showed better efficacy than its active
extracts, the loss of some bioactive component/s might lead to
PC3 cell death through a different mode of action. Other active
fractions showed a similar trend in activity when compared to
their active extracts but with better efficacy.
In this study, we have also decided to investigate the effect of
both plant extracts on the expression of ALOX5 gene. ALOX5 is a
gene responsible for the production of 5-LOX enzyme in human.
Ghosh and Myers (1997) reported that chemical constituents
such as arachidonic acid, an omega-6, polyunsaturated fatty acid
was found to stimulate prostate cancer cell growth via the 5-
LOX pathway. This has been recently corroborated by Yang et al.
(2012), who also point toward 12-LOX. The expression of 5-
LOX is normally restricted to specified immune cells such as
neutrophils, eosinophils, basophils, and macrophages whereas
the vast majority of non-immune body cells do not express 5-
LOX unless at the onset of certain diseases such as asthma,
arthritis, psoriasis, and cancer (Fürstenberger et al., 2006; Werz
and Steinhilber, 2006; Rådmark et al., 2007; Ghosh, 2008). 5-LOX
plays a very important role in chemotaxis in these cells. Ghosh
and Myers (1997) and Werz and Steinhilber (2006) reported
that the inhibition of 5-LOX would block the production of
5-LOX metabolites and triggers apoptosis in prostate cancer cells.
The expression of 5-LOX in normal prostate glands is almost
undetectable, however, 5-LOX is heavily expressed in prostate
tumor tissues including PC3 cell lines. However, this study shows
that the active extracts of both plants (FD1c and FD2c) did not
show any significant effect on the expression of ALOX5 gene. This
suggests that both active extracts induced prostate cancer cells
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death via other pathways, which are not related to the inhibition
of 5-LOX metabolites production.
This pro-apoptotic effect lead to a reduction of the cell
population in the G0/G1 phase, whereas those in the G2/M phase
was increased significantly when compared to the untreated PC3
cells. Cell cycle arrest specifically at the G2/M phase serves to
prevent cells with damaged genomic DNA from entering the
mitosis (M) phase.
Additionally, all anti-proliferative plant extracts (FD1c and
FD2c) displayed significant inhibitory effects on the migration
and invasion of PC3 cancer cell lines at non-toxic concentrations.
Further mechanistic studies showed that the active plant extracts
and their respective fractions (FD1c F43-51, FD2c F29-33, and
FD2c F34-36) were able to inhibit cell motility by modulating
CXCR4, CXCL12 gene expression. Increasing evidence indicate
that the tumor microenvironment (including tumor-stromal
cells interactions) have a crucial role in tumor initiation and
progression (Guo et al., 2015). Singh et al. (2004) reported that
CXCL12-CXCR4 interactions were able to modulate prostate
cancer cell migration and invasion. CXCL12 is a type of
chemokines that bind to and activate a family of chemokine
receptors (Vindrieux et al., 2009). CXCR4 is a type of chemokine
receptor that consists of seven-transmembrane receptors coupled
to G protein (Ransohoff, 2009). CXCL12 and chemokine
receptors CXCR4 and CXCR7, are the key factors that link
between cancer cells and their microenvironment. Functional
CXCR4 was reported to be expressed by prostate cancer cell
lines PC3 and LNCaP, as well as normal prostate epithelial cells
(PrEC). However, significantly higher levels of CXCR4 were
observed in the malignant cell lines such as PC3 and LNCaP
compared to the normal prostatic epithelial cells. Previous studies
conducted by Singh et al. (2004) shows that the number of
malignant prostate cancer cell lines that migrated in response
to CXCL12 was significantly higher than for cells not exposed
to CXCL12 as chemoattractant. Therefore, interruption to the
level of CXCL12 and disruption to CXCL12-CXCR4 litigation
could possibly lead to the inhibition of prostate cancer cells
migration and invasion. All the active extract of the plants and
their respective fractions were able to down-regulate the CXCL12
mRNA gene expression significantly. This might lead to the fall of
the production of CXCL12 chemokines and thus inhibiting both
PC3 cells migration and inhibition. However, only FD1c but not
its respective fraction (FD1c F43-5) was able to have a significant
effect on the expression of CXCR4.
Regarding the mRNA gene expression of VEGF, only FD1c
F43-51 had shown significant inhibition to the expression of the
gene. Vascular endothelial growth factor (VEGF) is known to
be a critical regulator of endothelial cell migration by increasing
endothelial cell permeability, stimulating proliferation, and
promoting migration of phosphatidylinositol-3-kinase and the
small GTPase Rac-1 (Soga et al., 2009). Apart from that, VEGF
also play a very important role in the formation of new blood
vessels from pre-existing capillaries and venules – a process called
angiogenesis. Overexpression of VEGF is normally seen in cancer
cells, as it is vital to help create the microenvironment that
would promote the growth of the cells. Therefore, by reducing
the expression of VEGF, the production of its protein will be
decreased and thus creating a microenvironment that is not
suitable for the cancer cells to migrate or invade. Despite the
cytotoxic effects of all the active plant extracts and their respective
fractions on prostate cancer cell lines, they showed specific
selectivity when tested with normal human dermal fibroblast cells
(HDFa).
The LC–MS dereplication of active fractions of Ficus spp.
identified isovitexin in FD1c F43-51; oleanolic acid, moretenol,
betulin, lupenone, and lupeol in FD2c F29-33; and oleanolic acid,
and lupenone in FD2c F34-36. Both isovitexin and moretenol
have been previously reported to be isolated from F. deltoidea
(Bunawan et al., 2014). However, this is the first time that
oleanolic acid, betulin, lupenone, and lupeol are identified in this
species. Oleanolic acid has been identified in Ficus microcarpa
(Ao et al., 2008), Ficus hispida Linn (Joseph and Raj, 2011), and
Ficus nervosa (Chen et al., 2010). Betulin was identified in Ficus
foveolata (Somwong et al., 2013), Ficus racemosa (Bopage, 2016),
and Ficus carica L. (Oliveira et al., 2012). Lupenone was identified
in Ficus pseudopalma (Ragasa et al., 2009), Ficus microcarpa (Kuo
and Lin, 2004), and Ficus sycomorus (Ahmadu et al., 2007). While,
lupeol has been previously identified in Ficus pseudopalma Blanco
(Santiago and Mayor, 2014), Ficus odorata (Tsai et al., 2012), and
Ficus polita Vahl (Kuete et al., 2011).
CONCLUSION
FD1c, FD2c and the respective active fractions were able to
overcome three main hallmarks of cancer in PC3 cells: (1)
apoptosis by activating of the intrinsic pathway, (2) inhibition
of both migration and invasion by modulating the CXCL12-
CXCR4 axis, and (3) inhibiting angiogenesis by modulating
VEGF-A expression. These activities can be concentrated
in phytochemically well-defined active fractions containing a
number of known and new (vitexin) cytotoxic compounds
toward PC3 cells.
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